Shoulder Innovations Initiates Full Commercial Launch of the InSet™ I-135RFX Humeral Stem

Latest Addition to I-Series Product Line Follows a Successful Limited Market Release and FDAClearance of Additional Fracture Indications GRAND RAPIDS, Mich., April 27, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the Company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced full commercial launch of the InSet™ I-135RFX Humeral Stem ("InSet™ I-135RFX").